GM

Ganesh Mallikarjun Biradar

Active Director Designated Partner DIN 10537908
DIN 10537908 First appointment Mar 2024
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Mar 2024
Shareholding value β€’β€’β€’β€’ Premium profile

About Ganesh Mallikarjun Biradar

Data last updated:

Ganesh Mallikarjun Biradar is a Designated Partner at Actolab Healthcare Llp (since 2024).

DIN 10537908
Primary Designation Designated Partner
First Appointment 06 Mar 2024
Oldest Company Age 2 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Designated Partner06 Mar 20242024Active

Board colleagues of Ganesh Mallikarjun Biradar

NameDINCompanyDesignation
Ganesh Shashikant Deshmukh06468366Actolab Healthcare LlpDesignated Partner
Swati Ganesh Deshmukh08406787Actolab Healthcare LlpDesignated Partner

Directorship timeline

Open interactive timeline →
Actolab Healthcare Llp
Premium access

Shareholding and investment profile for Ganesh Mallikarjun Biradar

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Ganesh Mallikarjun Biradar

Ganesh Mallikarjun Biradar currently holds 1 directorship: Actolab Healthcare Llp (Designated Partner, since 06 Mar 2024).

Ganesh Mallikarjun Biradar was first appointed on 06 Mar 2024 as Designated Partner at Actolab Healthcare Llp.

The current boards of Ganesh Mallikarjun Biradar's companies include Ganesh Shashikant Deshmukh (Actolab Healthcare Llp), Swati Ganesh Deshmukh (Actolab Healthcare Llp).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available